Publications

Find coverage of the latest original articles on Lupus, focusing on those with data on therapeutic interventions and those that have clinical impact.

Literature Highlights

Publications

Clear Search

Showing 1 result for “de la Torre I”.

March 2023
Publication thumbnail: Baricitinib for Systemic Lupus Erythematosus: a Double-blind, Randomised, Placebo-controlled, Phase 3 Trial (SLE-BRAVE-I) View Slides

Baricitinib for Systemic Lupus Erythematosus: a Double-blind, Randomised, Placebo-controlled, Phase 3 Trial (SLE-BRAVE-I)

, , , , , , , , , , , , ,

Lancet. 2023 doi: 10.1016/S0140-6736(22)02607-1

Primary endpoint in SLE-BRAVE-I study was met for the 4 mg baricitinib group, however, key secondary endpoints were not.

more…

Keywords: